Barclays analyst Andrew Lazar raised the firm’s price target on Kellanova to $64 from $60 and keeps an Equal Weight rating on the shares. The company believes consumers are in the later innings of adjusting their reference price points, underpinning its expectation for gradual sequential volume improvement, the analyst tells investors in a research note.